text: Metoclopramide Tablets (10 mg) PLIVA 430  round\nscored white \nGENERIC NAME: metoclopramide\nBRAND NAME: Reglan\nDRUG CLASS: Metoclopramide is a "prokinetic" agent that increases muscle tone of the lower esophagus sphincter. The lower esophagus sphincter, located between the esophagus and stomach, normally prevents reflux of acid and other stomach contents into the esophagus. In patients with Gastroesophageal Reflux (GERD), a weakened lower esophagus sphincter allows reflux of stomach acid into the esophagus, causing heart burn and acid damage to the esophagus (peptic esophagitis). Metoclopramide decreases stomach acid reflux by strengthening the lower esophagus sphincter. Like cisapride (Propulsid), metoclopramide also hastens the stomach emptying of solid and liquid meals into the intestines. Rapid emptying of meals also help decrease the reflux of stomach acid and other contents into the esophagus.\n\nMetoclopramide interferes with dopamine receptors in the brain. Since dopamine causes nausea. Metoclopramide can be an effective anti-nausea medication.\n\nWhile cisapride and metoclopramide are similar in decreasing gastroesophageal reflux, metoclopramide is more likely to cause nervous system side effects such as jitteriness, insomnia, sedation, or anxiety. \n\nPRESCRIPTION: no\n\nGENERIC AVAILABLE: yes\n\nPREPARATIONS: tablets: 5 mg and 10mg. Syrup: 5 mg/5 ml \n\nSTORAGE: Tablets and syrup should be stored at temperature between 15-30C \n(59-86F).\n\nPRESCRIBED FOR: Metoclopramide is used on a short term basis (4 to 12 weeks) for patients with heartburn and esophagitis due to gastroesophageal reflux. Please also read the Gastroesophageal Reflux (GERD) article. Stomach nerve damage due to diabetes (diabetic gastric stasis) can cause delayed stomach emptying, resulting in nausea, vomiting, fullness, and heartburn. Metoclopramide can be effective in relieving nausea and other symptoms related to diabetic gastric stasis. Metoclopramide is also used in the treatment of nausea related to postoperative state and cancer chemotherapy.\n\nDOSING: Metoclopramide is usually given four times daily, 30 minutes before each meal and at bedtime for the treatment of esophageal reflux. Dosage and frequency may be lowered in elderly patients, and in situations where symptoms occur only intermittently and at specific times. Concurrent administration of Anticholinergic medications can decrease the effectiveness of metoclopramide.\n\nDRUG INTERACTIONS: Metoclopramide can have nervous system side effects, such as depression, anxiety, sedation, restlessness, and insomnia. Parkinson patients can experience worsening of symptoms with metoclopramide. Metoclopramide may impair the mental and/or physical abilities to drive or operate machinery. Rarely, metoclopramide can cause involuntary muscle movements, facial grimacing, and dystonic reactions resembling tetanus. Since metoclopramide accelerates stomach emptying, it can increase absorption and effects of other medications. For example, the effects of sedatives such as alcohol and diazepam (Valium) can be accelerated when used together with metoclopramide. Safety in pregnancy, nursing mothers, and children has not been established.\n\nSIDE EFFECTS: Metoclopramide is generally well tolerated when used in low doses for brief periods. The nervous system side effects increase with higher doses and longer periods of treatment. The common side effects are mentioned above under Drug Interactions.\n\n\n 1   Glossary   metoclopramide